Yuyu Pharma, Inc. Logo

Yuyu Pharma, Inc.

000220 | KO

Overview

Corporate Details

ISIN(s):
KR7000220004
LEI:
Country:
South Korea
Address:
충청북도 제천시 바이오밸리1로 94, 제천시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 116.4 KB
2025-08-13 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-07-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 123.1 KB
2025-07-22 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 52.2 KB
2025-07-15 00:00
Transaction in Own Shares
자기주식취득결과보고서
Korean 67.0 KB
2025-07-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 117.4 KB
2025-05-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 67.6 KB
2025-05-22 00:00
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 12.6 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.4 MB
2025-04-22 00:00
Capital/Financing Update
주요사항보고서(자기전환사채만기전취득결정)
Korean 14.7 KB
2025-04-15 00:00
Capital/Financing Update
주요사항보고서(자기전환사채만기전취득결정)
Korean 24.0 KB
2025-04-15 00:00
Capital/Financing Update
기타경영사항(자율공시)
Korean 5.9 KB
2025-04-11 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득결정)
Korean 32.8 KB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 14.0 KB
2025-03-27 00:00
AGM Information
정기주주총회결과
Korean 32.9 KB

Automate Your Workflow. Get a real-time feed of all Yuyu Pharma, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Yuyu Pharma, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Yuyu Pharma, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Arcus Biosciences, Inc. Logo
A clinical-stage biopharma developing small molecule and antibody combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes non-steroidal therapies for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharma developing first-in-class drugs for cardiorenal and GI diseases like IBS-C and CKD.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom
AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America
AVBP
ARROWHEAD PHARMACEUTICALS, INC. Logo
Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.
United States of America
ARWR
ARS Pharmaceuticals, Inc. Logo
Develops the first FDA-approved, needle-free epinephrine spray for severe allergic reactions.
United States of America
SPRY

Talk to a Data Expert

Have a question? We'll get back to you promptly.